Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The influence of HER2 genotypes as molecular markers in ovarian cancer outcome.

Biochemical and biophysical research communications - 7 Oct 2005

Pinto Daniela, Pereira Deolinda, Portela Catarina, da Silva José Leal, Lopes Carlos, Medeiros Rui

Abstract excerpt

A relevant clinical problem in the treatment of ovarian cancer (OC) is the development of resistance to chemotherapy, frequently due to genetic variations in enzymes and receptors. Changes in the HER2 receptor have been associated with breast and ovarian cancers. The role of a polymorphism in the HER2 gene in the clinical outcome of OC patients was investigated in this study. We characterized DNA samples from 111...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Incidence
Share to Ovarian Neoplasms

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Portugal

Share to Receptor, ErbB-2

Share to Risk Assessment

Share to Sensitivity and Specificity

Share to Survival Analysis

Share to Survival Rate

Source

Identifiers

PMID: 16112085
DOI: 10.1016/j.bbrc.2005.08.012

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The influence of HER2 genotypes as molecular markers in ovarian cancer outcome.PMID 16112085Read ↗

The influence of HER2 genotypes as molecular markers on breast cancer outcome.Semantic proximity Read ↗

‘Genetic profiling’ and ovarian cancer therapy (Review)Semantic proximity Read ↗

Somatic Mutations in HER2 and Implications for Current Treatment Paradigms in HER2-Positive Breast CancerSemantic proximity Read ↗

CCR2-V64I genetic polymorphism: a possible involvement in HER2+ breast cancer.Semantic proximity Read ↗

Genetic markers for prediction of treatment outcomes in ovarian cancer.Semantic proximity Read ↗

Are CYP17 genotypes a biomarker for ovarian cancer in patients with cancer history in their family?Semantic proximity Read ↗

Genetic variants in the HER2 gene: Influence on HER2 overexpression and loss of heterozygosity in breast cancer.Semantic proximity Read ↗

Association of HER2 codon 655 polymorphism with ovarian cancer.Semantic proximity Read ↗

The CYP1A1 Ile462Val polymorphism and platinum resistance of epithelial ovarian neoplasms.Semantic proximity Read ↗

Evaluation of human epidermal growth factor receptor 2 (HER2) single nucleotide polymorphisms (SNPs) in normal and breast tumor tissues and their link with breast cancer prognostic factors.Semantic proximity Read ↗

Polymorphism and overexpression of HER2/neu among ovarian carcinoma women from Tiruchirapalli, Tamil Nadu, India.Semantic proximity Read ↗

The influence of serum HER-2 levels and HER-2 codon 655 polymorphism on breast cancer outcome.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.